Cargando…
Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites
In this work, nanohydroxyapatite (HAp) was functionalized with poly(ε-caprolactone) (PCL), using 1,6-hexamethylene diisocyanate (HDI) as a coupling agent, and then incorporated into the polyoxymethylene copolymer (POM) matrix using the extrusion technique. The obtained POM/HAp-g-PCL composites were...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912578/ https://www.ncbi.nlm.nih.gov/pubmed/35269346 http://dx.doi.org/10.3390/nano12050858 |
_version_ | 1784667174783156224 |
---|---|
author | Pielichowska, Kinga Szuba, Paula Maciocha, Joanna Macherzyńska, Beata Nowicka, Katarzyna Szatkowski, Piotr |
author_facet | Pielichowska, Kinga Szuba, Paula Maciocha, Joanna Macherzyńska, Beata Nowicka, Katarzyna Szatkowski, Piotr |
author_sort | Pielichowska, Kinga |
collection | PubMed |
description | In this work, nanohydroxyapatite (HAp) was functionalized with poly(ε-caprolactone) (PCL), using 1,6-hexamethylene diisocyanate (HDI) as a coupling agent, and then incorporated into the polyoxymethylene copolymer (POM) matrix using the extrusion technique. The obtained POM/HAp-g-PCL composites were investigated using FTIR, DSC, TOPEM DSC, and TG methods. Mechanical properties were studied using destructive and non-destructive ultrasonic methods, wettability, and POM crystallization kinetics in the presence of HAp-g-PCL. Moreover, preliminary bioactivity evaluation of the POM/HAp-g-PCL composites was performed using the Kokubo method. It was found that the introduction of HAp-g-PCL to the POM matrix has a limited effect on the phase transitions of POM as well as on its degree of crystallinity. Importantly, HAp grafted with PCL caused a significant increase in the thermal stability of the POM, from 292 °C for pristine POM to 333 °C for POM modified with 2.5% HAp-g-PCL. If unmodified HAp was used, a distinct decrease in the thermal stability of the POM was observed. Crystallization kinetic studies confirmed that HAp-g-PCL, in small amounts, can act as a nucleating agent for the POM crystallization process. Moreover, incorporation of HAp-g-PCL, although slightly decreasing the mechanical properties of POM composites, improved the crucial parameter in biomedical applications, namely the in vitro bioactivity. |
format | Online Article Text |
id | pubmed-8912578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89125782022-03-11 Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites Pielichowska, Kinga Szuba, Paula Maciocha, Joanna Macherzyńska, Beata Nowicka, Katarzyna Szatkowski, Piotr Nanomaterials (Basel) Article In this work, nanohydroxyapatite (HAp) was functionalized with poly(ε-caprolactone) (PCL), using 1,6-hexamethylene diisocyanate (HDI) as a coupling agent, and then incorporated into the polyoxymethylene copolymer (POM) matrix using the extrusion technique. The obtained POM/HAp-g-PCL composites were investigated using FTIR, DSC, TOPEM DSC, and TG methods. Mechanical properties were studied using destructive and non-destructive ultrasonic methods, wettability, and POM crystallization kinetics in the presence of HAp-g-PCL. Moreover, preliminary bioactivity evaluation of the POM/HAp-g-PCL composites was performed using the Kokubo method. It was found that the introduction of HAp-g-PCL to the POM matrix has a limited effect on the phase transitions of POM as well as on its degree of crystallinity. Importantly, HAp grafted with PCL caused a significant increase in the thermal stability of the POM, from 292 °C for pristine POM to 333 °C for POM modified with 2.5% HAp-g-PCL. If unmodified HAp was used, a distinct decrease in the thermal stability of the POM was observed. Crystallization kinetic studies confirmed that HAp-g-PCL, in small amounts, can act as a nucleating agent for the POM crystallization process. Moreover, incorporation of HAp-g-PCL, although slightly decreasing the mechanical properties of POM composites, improved the crucial parameter in biomedical applications, namely the in vitro bioactivity. MDPI 2022-03-03 /pmc/articles/PMC8912578/ /pubmed/35269346 http://dx.doi.org/10.3390/nano12050858 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pielichowska, Kinga Szuba, Paula Maciocha, Joanna Macherzyńska, Beata Nowicka, Katarzyna Szatkowski, Piotr Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites |
title | Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites |
title_full | Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites |
title_fullStr | Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites |
title_full_unstemmed | Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites |
title_short | Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites |
title_sort | preparation, characterization, and bioactivity evaluation of polyoxymethylene copolymer/nanohydroxyapatite-g-poly(ε-caprolactone) composites |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912578/ https://www.ncbi.nlm.nih.gov/pubmed/35269346 http://dx.doi.org/10.3390/nano12050858 |
work_keys_str_mv | AT pielichowskakinga preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites AT szubapaula preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites AT maciochajoanna preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites AT macherzynskabeata preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites AT nowickakatarzyna preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites AT szatkowskipiotr preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites |